The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease

Brain Research

Volumn 1384, Issue , 2011, Pages 69-79

  Zhang, Qiao Jun ^a   Li, Li Bo ^a   Niu, Xiao Lin ^a   Liu, Jian ^a   Gui, Zhen Hua ^a   Feng, Jian Jun ^a   Ali, Umar ^a   Hui, Yan Pin ^a   Wu, Zhong Heng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

5 Hydroxytryptamine 3 receptors; Extracellular recording; Medial prefrontal cortex; Parkinson's disease; Pyramidal neurons

Indexed keywords

4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; BICUCULLINE; OXIDOPAMINE; SEROTONIN 3 RECEPTOR; TROPISETRON; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CELL ACTIVITY; CELL COUNT; CONTROLLED STUDY; DRUG MECHANISM; GABAERGIC SYSTEM; MALE; NONHUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; BICUCULLINE; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA-A RECEPTOR ANTAGONISTS; INDOLES; MALE; OXIDOPAMINE; PARKINSON DISEASE; PIPERIDINES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGENTS; STATISTICS, NONPARAMETRIC; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

RATTUS; RODENTIA;

EID: 79953028130     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.01.086     Document Type: Article

References (57)

1. N.C. Andreasen, D.S. O'Leary, M. Flaum, P. Nopoulos, G.L. Watkins, L.L. Boles Ponto, and R.D. Hichwa Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patient Lancet 349 1997 1730 1734 (Pubitemid 27252672)
2. 3-like receptors in the rat medial prefrontal cortex: an electrophysiological study Brain Res. 550 1991 181 191
3. C.R. Ashby, E. Edwards, K. Harkins, and R.Y. Wang Characterization of 5-hydroxytryptamine3 receptors in the medial prefrontal cortex: a microiontophoretic study Eur. J. Pharmacol. 173 1989 193 196 (Pubitemid 20012352)
4. C.R. Ashby, E. Edwards, and R.Y. Wang Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors Synapse 10 1992 7 15
5. 3 receptors in vitro and in vivo Eur. J. Pharmacol. 237 1993 299 309 (Pubitemid 23201840)
6. P. Blier, and F.V. Abbott Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain J. Psychol. Neurosci. 26 2001 37 43 (Pubitemid 32185178)
7. S. Breit, R. Bouali-Benazzouz, A.L. Benabid, and A. Benazzouz Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat Eur. J. Neurosci. 14 2001 1833 4182
8. J. Chen, W. Paredes, H.M. Van Praag, J.H. Lowinson, and E.L. Gardner Presynaptic dopamine release is enhanced by 5-HT receptor activation in medial prefrontal cortex of freely moving rats Synapse 10 1992 264 266
9. 3 binding sites following a unilateral 6-hydroxydopamine lesion of the medial forebrain bundle in rats J. Neurol. Sci. 115 1993 105 110 (Pubitemid 23090193)
10. 3 receptors are membrane ion channels Nature 33 1989 706 709
11. W.C. Drevets Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders Curr. Opin. Neurobiol. 11 2001 240 249 (Pubitemid 32289413)
12. W.C. Drevets, J.L. Price, J.R. Simpson, R.D. Todd, T. Reich, M. Vannier, and M.E. Raichle Subgenual prefrontal cortex abnormalities in mood disorders Nature 386 1997 824 827 (Pubitemid 27181254)
13. S.M. Dursun, J.R. Blackburn, and S.P. Kutcher An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap Med. Hypoth. 56 2001 235 243 (Pubitemid 32202635)
14. M. Fedrowitz, S. Lindemann, W. Loscher, and M. Gernert Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant Neuroscience 118 2003 867 878 (Pubitemid 36506972)
15. 3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons J. Neurosci. 22 2002 7389 7397 (Pubitemid 35386338)
16. 3 receptor antagonists and anti-emetic mechanisms of action Anticancer Drugs 3 1992 79 85
17. T.F. Freund Interneuron diversity series: rhythm and mood in perisomatic inhibition Trends Neurosci. 26 2003 489 495 (Pubitemid 37025787)
18. T.F. Freund, A.I. Gulyas, L. Acsady, T. Gorcs, and K. Toth Serotonergic control of the hippocampus via local inhibitory interneurons Proc. Natl. Acad. Sci. U. S. A. 87 1990 8501 8505
19. A.C. Grobin, and A.Y. Deutch Dopaminergic regulation of extracellular γ-aminobutyric acid levels in the prefrontal cortex of the rat J. Pharmacol. Exper. Ther. 285 1998 350 357 (Pubitemid 28207606)
20. H.J. Groenewegen, and H.B. Uylings The prefrontal cortex and the integration of sensory limbic and autonomic information Prog. Brain Res. 126 2000 3 28 (Pubitemid 35461278)
21. 7 receptor in rat brain Br. J. Pharmacol. 117 1996 657 666 (Pubitemid 26074120)
22. 1A receptors Neuropharmacology 45 2003 72 81 (Pubitemid 36695012)
23. G.A. Higgins, and G.J. Kilpatrick 5-HT(3) receptor antagonists Expert Opin. Invest. Drugs 8 1999 2183 2188
24. K. Kurata, C.R. Ashby Jr., R. Oberlender, Y. Tanii, M. Kurachi, N.J. Rini, and R.E. Strecker The characterization of the effect of locally applied N-methylquipazine, a 5-HT receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: an in vivo microdialysis study Synapse 24 1996 313 321 (Pubitemid 26418683)
25. A.C. Lanoue, A. Dumitriu, R.H. Myers, and J. Soghomonian Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease Exp. Neurol. 226 2010 207 217
26. D. Law-Tho, J.C. Hirsch, and F. Crepel Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study Neurosci. Res. 21 1994 151 160
27. H.G. Lidov, R. Grzanna, and M.E. Molliver The serotonin innervation of the cerebral cortex in the rat: an immunohistochemical analysis Neuroscience 5 1980 207 227 (Pubitemid 10169345)
28. M. Lohle, A. Storch, and H. Reichmann Beyond tremor and rigidity: non-motor features of Parkinson's disease J. Neural Transm. 116 2009 1483 1492
29. H. Markram, M. Toledo-Rodriguez, Y. Wang, A. Gupta, G. Silberberg, and C.Z. Wu Interneurons of the neocortical inhibitory system Nat. Rev. Neurosci. 5 2004 793 807 (Pubitemid 39336216)
30. D.N. Middlemiss, G.W. Price, and J.M. Watson Serotonergic targets in depression Curr. Opin. Pharmacol. 2 2002 18 22
31. E.K. Miller, and J.D. Cohen An integrative theory of prefrontal cortex function Annu. Rev. Neurosci. 24 2001 167 202 (Pubitemid 32695227)
32. J.C. Monfort, F. Javoyagid, J.J. Hauw, B. Dubois, and Y. Agid Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index Brain 108 1985 301 313 (Pubitemid 15064797)
33. M. Morales, E. Battenberg, L. de Lecea, and F.E. Bloom The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus Brain Res. 731 1996 199 202 (Pubitemid 26294923)
34. M. Morales, E. Battenberg, L. de Lecea, P.P. Sanna, and F.E. Bloom Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system Mol. Brain Res. 36 1996 251 260 (Pubitemid 26095584)
35. 3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon J. Neurosci. 17 1997 3157 3167 (Pubitemid 27175828)
36. A receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease Jpn J. Pharmacol. 48 1988 331 339 (Pubitemid 18259443)
37. E.C. Papp, N. Hajos, L. Acsady, and T.F. Freund Medial septal and median raphe innervation of vasoactive intestinal polypeptide-containing interneurons in the hippocampus Neuroscience 90 1999 369 382 (Pubitemid 29161387)
38. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 5th. Ed. 2005 Academic Press New York
39. 1A receptor in the rat brain: correlation with receptor binding J. Neurosci. 12 1992 440 453
40. 2C receptors Mol. Brain Res. 23 1994 163 178
41. 3 receptors Cereb. Cortex 14 2004 1365 1375 (Pubitemid 39507287)
42. 1B receptors on globus pallidus neuronal spiking Brain Res. 1043 2005 186 194 (Pubitemid 40603386)
43. 3 receptors in developing visual cortex J. Neurosci. 17 1997 8353 8362 (Pubitemid 27461058)
44. N. Santana, A. Bortolozzi, J. Serrats, G. Mengod, and F. Artigas Expression of serotonin-1A and serotonin-2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex Cereb. Cortex 14 2004 1100 1109 (Pubitemid 39258165)
45. B. Scholtissen, F.R. Verhey, H.W. Steinbusch, and A.F. Leentjens Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data J. Neural Transm. 113 2006 59 73 (Pubitemid 41828957)
46. S.R. Sesack, and B.S. Bunney Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study J. Pharmacol. Exper. Ther. 248 1989 1323 1333 (Pubitemid 19100791)
47. L.M. Shulman, R.L. Taback, J. Bean, and W.J. Weiner Comorbidity of the nonmotor symptoms of Parkinson's disease Mov. Disord. 16 2001 507 510 (Pubitemid 36041156)
48. H.W.M. Steinbusch Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals Neuroscience 6 1981 557 618 (Pubitemid 11102583)
49. K. Taghzouti, M. Le Moal, and H. Simon Suppression of noradrenergic innervation compensates for behavioral deficits induced by lesion of dopaminergic terminals in the lateral septum Brain Res. 552 1991 124 128
50. P.L. Tierney, E. Degenetais, A.M. Thierry, J. Glowinski, and Y. Gioanni Influence of the hippocampus on interneurons of the rat prefrontal cortex Eur. J. Neurosci. 20 2004 514 524 (Pubitemid 38969636)
51. K.Y. Tseng, N. Mallet, K. Toreson, C.L. Moine, F.O. Gonon, and A.P. O'Donnell Excitatory response of prefrontal cortical fast-spiking interneurons to ventral tegmental area stimulation in vivo Synapse 59 2006 412 417
52. 2A/2C receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease Exp. Neurol. 219 2009 239 248
53. S. Wang, Q.J. Zhang, J. Liu, Z.H. Wu, U. Ali, Y. Wang, L. Chen, and Z.H. Gui The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease Neuroscience 162 2009 1091 1100
54. 1A receptor stimulation in the rat Neuroscience 159 2009 850 861
55. F.M. Zhou, and J.J. Hablitz Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex J. Neurophysiol. 82 1999 2989 2999 (Pubitemid 30017427)
56. T. Ziemssen, and H. Reichmann Non-motor dysfunction in Parkinson's disease Parkinsonism Relat. Disord. 13 2007 323 332 (Pubitemid 47212791)
57. 3 receptor antagonist Neurology 45 1995 1305 1308